Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas

A. Viel, L. Dall'Agnese, F. Simone, V. Canzonieri, E. Capozzi, M. C. Visentin, R. Valle, M. Boiocchi

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

The high-affinity folate-binding protein (FBP) is primarily involved in the uptake of the 5-methyltetrahydrofolate, and its expression may be physiologically regulated by the intracellular folate content. The overexpression of FBP on the cell surface of ovarian carcinoma cells may be responsible for an increased folate uptake. We tested the hypothesis of the existence of a defect in the 5,10-methylenetetrahydrofolate reductase (MTHFR) in ovarian tumours that could cause reduced intracellular regeneration of the 5-methyltetrahydrofolate elate and induce increased FBP expression. No sequence mutations were found in the MTHFR gene, but allelic deletions of this gene were frequently detected in ovarian tumours (59%). Chromosomal losses appeared to be confined to the 1p36.3 region to which the MTHFR gene maps. Although it cannot be stated that MTHFR is the target gene of the chromosomal loss involving the 1p36.3 region, a correlation between loss of heterozygosity at this locus and decrease in MTHFR activity was shown, suggesting a role of these allelic deletions in generating a biochemical defect in folate metabolism. Further studies are needed to assess further the relationship between MTHFR and FBP overexpression, but the demonstration of the alteration of a key metabolic enzyme of the folate cycle in a subset of human ovarian tumours is in accordance with the hypothesis of an altered folate metabolism in these neoplasias and might be exploited for therapeutic purposes.

Original languageEnglish
Pages (from-to)1105-1110
Number of pages6
JournalBritish Journal of Cancer
Volume75
Issue number8
Publication statusPublished - 1997

Fingerprint

Methylenetetrahydrofolate Reductase (NADPH2)
Loss of Heterozygosity
Folic Acid
Carcinoma
Carrier Proteins
Neoplasms
Genes
Gene Deletion
Regeneration
Mutation

Keywords

  • 5,10-methylenetetrahydrofolate reductase
  • Folate
  • Folate-binding protein
  • Loss of heterozygosity
  • Ovarian carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Viel, A., Dall'Agnese, L., Simone, F., Canzonieri, V., Capozzi, E., Visentin, M. C., ... Boiocchi, M. (1997). Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. British Journal of Cancer, 75(8), 1105-1110.

Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. / Viel, A.; Dall'Agnese, L.; Simone, F.; Canzonieri, V.; Capozzi, E.; Visentin, M. C.; Valle, R.; Boiocchi, M.

In: British Journal of Cancer, Vol. 75, No. 8, 1997, p. 1105-1110.

Research output: Contribution to journalArticle

Viel, A, Dall'Agnese, L, Simone, F, Canzonieri, V, Capozzi, E, Visentin, MC, Valle, R & Boiocchi, M 1997, 'Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas', British Journal of Cancer, vol. 75, no. 8, pp. 1105-1110.
Viel, A. ; Dall'Agnese, L. ; Simone, F. ; Canzonieri, V. ; Capozzi, E. ; Visentin, M. C. ; Valle, R. ; Boiocchi, M. / Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. In: British Journal of Cancer. 1997 ; Vol. 75, No. 8. pp. 1105-1110.
@article{337bef9ec3de4629b9fff0fffa1c635e,
title = "Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas",
abstract = "The high-affinity folate-binding protein (FBP) is primarily involved in the uptake of the 5-methyltetrahydrofolate, and its expression may be physiologically regulated by the intracellular folate content. The overexpression of FBP on the cell surface of ovarian carcinoma cells may be responsible for an increased folate uptake. We tested the hypothesis of the existence of a defect in the 5,10-methylenetetrahydrofolate reductase (MTHFR) in ovarian tumours that could cause reduced intracellular regeneration of the 5-methyltetrahydrofolate elate and induce increased FBP expression. No sequence mutations were found in the MTHFR gene, but allelic deletions of this gene were frequently detected in ovarian tumours (59{\%}). Chromosomal losses appeared to be confined to the 1p36.3 region to which the MTHFR gene maps. Although it cannot be stated that MTHFR is the target gene of the chromosomal loss involving the 1p36.3 region, a correlation between loss of heterozygosity at this locus and decrease in MTHFR activity was shown, suggesting a role of these allelic deletions in generating a biochemical defect in folate metabolism. Further studies are needed to assess further the relationship between MTHFR and FBP overexpression, but the demonstration of the alteration of a key metabolic enzyme of the folate cycle in a subset of human ovarian tumours is in accordance with the hypothesis of an altered folate metabolism in these neoplasias and might be exploited for therapeutic purposes.",
keywords = "5,10-methylenetetrahydrofolate reductase, Folate, Folate-binding protein, Loss of heterozygosity, Ovarian carcinoma",
author = "A. Viel and L. Dall'Agnese and F. Simone and V. Canzonieri and E. Capozzi and Visentin, {M. C.} and R. Valle and M. Boiocchi",
year = "1997",
language = "English",
volume = "75",
pages = "1105--1110",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas

AU - Viel, A.

AU - Dall'Agnese, L.

AU - Simone, F.

AU - Canzonieri, V.

AU - Capozzi, E.

AU - Visentin, M. C.

AU - Valle, R.

AU - Boiocchi, M.

PY - 1997

Y1 - 1997

N2 - The high-affinity folate-binding protein (FBP) is primarily involved in the uptake of the 5-methyltetrahydrofolate, and its expression may be physiologically regulated by the intracellular folate content. The overexpression of FBP on the cell surface of ovarian carcinoma cells may be responsible for an increased folate uptake. We tested the hypothesis of the existence of a defect in the 5,10-methylenetetrahydrofolate reductase (MTHFR) in ovarian tumours that could cause reduced intracellular regeneration of the 5-methyltetrahydrofolate elate and induce increased FBP expression. No sequence mutations were found in the MTHFR gene, but allelic deletions of this gene were frequently detected in ovarian tumours (59%). Chromosomal losses appeared to be confined to the 1p36.3 region to which the MTHFR gene maps. Although it cannot be stated that MTHFR is the target gene of the chromosomal loss involving the 1p36.3 region, a correlation between loss of heterozygosity at this locus and decrease in MTHFR activity was shown, suggesting a role of these allelic deletions in generating a biochemical defect in folate metabolism. Further studies are needed to assess further the relationship between MTHFR and FBP overexpression, but the demonstration of the alteration of a key metabolic enzyme of the folate cycle in a subset of human ovarian tumours is in accordance with the hypothesis of an altered folate metabolism in these neoplasias and might be exploited for therapeutic purposes.

AB - The high-affinity folate-binding protein (FBP) is primarily involved in the uptake of the 5-methyltetrahydrofolate, and its expression may be physiologically regulated by the intracellular folate content. The overexpression of FBP on the cell surface of ovarian carcinoma cells may be responsible for an increased folate uptake. We tested the hypothesis of the existence of a defect in the 5,10-methylenetetrahydrofolate reductase (MTHFR) in ovarian tumours that could cause reduced intracellular regeneration of the 5-methyltetrahydrofolate elate and induce increased FBP expression. No sequence mutations were found in the MTHFR gene, but allelic deletions of this gene were frequently detected in ovarian tumours (59%). Chromosomal losses appeared to be confined to the 1p36.3 region to which the MTHFR gene maps. Although it cannot be stated that MTHFR is the target gene of the chromosomal loss involving the 1p36.3 region, a correlation between loss of heterozygosity at this locus and decrease in MTHFR activity was shown, suggesting a role of these allelic deletions in generating a biochemical defect in folate metabolism. Further studies are needed to assess further the relationship between MTHFR and FBP overexpression, but the demonstration of the alteration of a key metabolic enzyme of the folate cycle in a subset of human ovarian tumours is in accordance with the hypothesis of an altered folate metabolism in these neoplasias and might be exploited for therapeutic purposes.

KW - 5,10-methylenetetrahydrofolate reductase

KW - Folate

KW - Folate-binding protein

KW - Loss of heterozygosity

KW - Ovarian carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0030993597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030993597&partnerID=8YFLogxK

M3 - Article

C2 - 9099956

AN - SCOPUS:0030993597

VL - 75

SP - 1105

EP - 1110

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 8

ER -